User profiles for "author:Sara Leddy"

Sara Leddy

UCL
Verified email at qmul.ac.uk
Cited by 81

Validating a novel web-based method to capture disease progression outcomes in multiple sclerosis

S Leddy, S Hadavi, A McCarren, G Giovannoni… - Journal of …, 2013 - Springer
Abstract The Expanded Disability Status Scale (EDSS) is the current 'gold standard'for
monitoring disease severity in multiple sclerosis (MS). The EDSS is a physician-based …

[HTML][HTML] Social cognition in type 1 myotonic dystrophy–A mini review

S Leddy, M Cercignani, L Serra, M Bozzali - Cortex, 2021 - Elsevier
Our ability to interact with those around us plays an important role in our relationships,
mental well being and ability to successfully navigate the complex social society in which we …

[HTML][HTML] Lesion distribution and substrate of white matter damage in myotonic dystrophy type 1: Comparison with multiple sclerosis

S Leddy, L Serra, D Esposito, C Vizzotto, G Giulietti… - NeuroImage: Clinical, 2021 - Elsevier
Abstract Myotonic Dystrophy type 1 (DM1) is an autosomal dominant condition caused by
expansion of the CTG triplet repeats within the myotonic dystrophy protein of the kinase …

Optic neuritis with potential for poor outcome

SA Cooper, SG Leddy, NT Skipper, VJM Barrett… - Practical …, 2022 - pn.bmj.com
The Optic Neuritis Treatment Trial previously reported that corticosteroids accelerated visual
recovery in optic neuritis (ON) without improving outcome. This finding related largely to …

Assessing fracture risk in people with MS: a service development study comparing three fracture risk scoring systems

R Dobson, SG Leddy, S Gangadharan… - BMJ open, 2013 - bmjopen.bmj.com
Objectives Suboptimal bone health is increasingly recognised as an important cause of
morbidity. Multiple sclerosis (MS) has been consistently associated with an increased risk of …

Depression in MS: a systematic review and meta-analysis

S Leddy, AJ Fowler, G Giovanonni… - Journal of Neurology …, 2014 - jnnp.bmj.com
Background Depression is a potentially treatable condition which can co-exist with multiple
sclerosis (MS). To date, the existing literature has not been collated in a systematic fashion …

Evaluation of remote assessments for multiple sclerosis in an in-home setting

A Kuri, BM Jacobs, S Leddy, K Schmierer… - Multiple Sclerosis and …, 2021 - Elsevier
Background There is an urgent clinical need for reliable remote monitoring methods in
Multiple Sclerosis (MS). We evaluated the use of remotely patient-recorded timed 25-foot …

216 Lesion distribution and substrate in type 1 myotonic dystrophy: comparison with multiple sclerosis

S Leddy, L Serra, D Esposito, C Vizzotto, G Silvestri… - 2022 - jnnp.bmj.com
Introduction This study compares the white matter lesion distribution and substrate between
patients with type one myotonic dystrophy (DM1) and patients with Multiple Sclerosis (MS) …

128 Visuoperceptual deficits as measures of cognitive dysfunction in multiple sclerosis: a pilot study

V Whitford, S Leddy, S Waters… - Journal of …, 2022 - search.proquest.com
Objective We investigated whether computerised measurement of visuoperceptual deficits
can detect cognitive dysfunction in multiple sclerosis (MS). Methods We assessed people …

091 Evaluation of remote assessments for multiple sclerosis in a real-world setting

A Kuri, BM Jacobs, S Leddy… - Journal of …, 2022 - search.proquest.com
Background There is an urgent need for reliable methods to remotely monitor Multiple
Sclerosis (MS). Existing assessments, such as Timed 25-Foot Walk (T25FW) and 9-Hole …